Mend
MEND is a Life sciences and biotechnology company with a mission to help people to heal.
The leading biotechnology company focused on nutritional science research.
Working with leading hospitals and universities on developing evidence based clinical nutrition products to enhance patient outcomes. We're very proud to have earned the trust of some of the most demanding and discerning clients in medicine, US special forces and professional sports
A group driven by personal experiences and modern science.
Life happens and so does the daily wear and tear that comes with living. We all go through some health challenges in our lives. Whether personally or with family members, we have to deal with pains and frustrations associated with the healing process, including our mend™ founders.
We realized that our personal experiences have served to expose the gaps in our healthcare system, and help identify areas we wanted to impact and improve.
At mend, we realize we’re all in this together. Any breakthroughs in healing we bring forth will benefit everyone, everywhere. We believe in the power of healing and in making it available to people who want to repair, recover, and return to life faster and better.
Live life mindfully. Live life mendfully.
In the News
Mend Appoints Acclaimed Digital Health Leader Paul Roscoe as CEO
Mend has appointed veteran digital health executive Paul Roscoe as CEO to lead its next phase of growth, as the company expands its evidence-based, nutrition-powered health platform for clinical recovery and wellness, while founder Eziah Syed transitions to Chief of Growth & Innovation.
Mend Receives $15 Million Series A Funding Led by S2G Ventures and Joined by a Syndicate of Leading VCs
Mend has secured $15 million in Series A funding led by S2G Ventures to scale its clinically proven nutrapharma and digital health platform, aiming to transform patient care by enhancing surgical recovery, chronic care, and overall health through science-backed nutrition and AI-enabled behavioral support.